Skip to main content
. 2022 Jan 30;11(3):766. doi: 10.3390/jcm11030766

Table 2.

Cardiovascular risk factors in axial PsA, peripheral PsA and AS groups. Differences statistically significant with p < 0.05 are marked.

Cardiovascular Risk Factors AS
n = 94
Axial PsA
n = 14
Peripheral PsA
n = 47
p
chi2
Post Hoc Tests
p
(AS vs. axPsA)
p
(AS vs. perPsA)
p
(axPsA vs. perPsA)
Smoking more than 1 cigarette per day for 30 days 43 (45.7%) 3 (21.4%) 21 (44.7%) ns ns ns ns
Physical activity more than 120 min twice weekly 21 (22.3%) 2 (14.3%) 11 (23.4%) ns ns ns ns
Hyperuricemia 13 (13.8%) 5 (35.7%) 3 (6.4%) ns ns ns ns
Hypertriglyceridemia 15 (16%) 2 (14.3%) 23 (48.9%) <0.001 <0.001 <0.001 <0.001
Obesity BMI > 30kg/m2 16 (17%) 3 (21.4%) 20 (42.6%) ns ns ns ns
Dyslipidemia in patients older than 40 years old 17 (18.1%) 3 (21.4%) 7 (14.9%) ns ns ns ns
Dyslipidemia in patients younger than 40 years old 24 (25.5%) 4 (28.6%) 12 (25.5%) ns ns ns ns
Hypertension 30 (32%) 5 (35.7%) 21 (44.78%) ns ns ns ns
Ischaemic heart disease 9 (9.6%) 0 (0.00%) 14 (29.8%) 0.002 0.05 0.05 0.049

p chi2—value for null hypothesis for Chi2 test. AS—ankylosing spondylitis, axPsA—PsA patients with the axial disease. perPsA—PsA patients with peripheral joint inflammation.